Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06651632 · ClinicalTrials.gov registry record · NA

WATER IV Prostate Cancer

A NA study of Localized Prostate Cancer, sponsored by PROCEPT BioRobotics.

Recruiting
Registry status
NA
Development phase
280
Enrollment target
20
Study locations

NCT06651632 is a NA study of Localized Prostate Cancer that is actively recruiting participants, run by PROCEPT BioRobotics. The registered enrollment target is 280 participants, above the 71-participant average among 6 other Localized Prostate Cancer trials with a reported enrollment target (294% higher). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06651632, a NA study of Localized Prostate Cancer, is actively recruiting participants, sponsored by PROCEPT BioRobotics.

RECRUITING
Registry status
NA
Development phase
280 participants
Enrollment target
20
Study locations

Study Summary

This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will be randomized to either Aquablation Therapy or radical prostatectomy and followed up to 10 years.

Conditions Studied

Localized Prostate Cancer

Interventions

  • PROCEDURE Radical Prostatectomy
  • DEVICE Aquablation Therapy

Study Locations (20)

Florida

  • Advanced Research - Delray Beach
  • University of Miami - Miami
  • Florida Urology Partners - Tampa
  • Trophy Point Urology - Tampa

Arizona

  • Arizona State Urological Institute - Chandler
  • East Valley Urology Center - Mesa

Illinois

  • University of Chicago - Chicago
  • Endeavor Health - Glenview

Nebraska

  • Kearney Urology Center - Kearney
  • Adult & Pediatric Urology - Omaha

New York

  • Integrated Medical Professionals, PLLC - New York
  • University of Rochester Medical Center - Rochester

California

  • University of Southern California - Los Angeles

Colorado

  • Boulder Medical Center - Boulder

Georgia

  • Georgia Urology - Atlanta

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2025-02-03
Est. Completion 2037-01
Phase NA

Sponsor

PROCEPT BioRobotics

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06651632

The ClinicalTrials.gov registry entry for NCT06651632 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 71-participant average among 6 other Localized Prostate Cancer trials with a reported enrollment target (294% higher). The listed sponsor is PROCEPT BioRobotics, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Localized Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Radical Prostatectomy is the first listed.

NCT06651632 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Arizona, Illinois.

Frequently Asked Questions

What is clinical trial NCT06651632 about?

NCT06651632 is a clinical study titled "WATER IV Prostate Cancer". This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will be randomized to ei...

What is the current status of trial NCT06651632?

This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2025-02-03. Estimated completion is 2037-01.

What conditions does trial NCT06651632 study?

This clinical trial studies the following conditions: Localized Prostate Cancer.

What interventions are being tested in trial NCT06651632?

The interventions under investigation include: Radical Prostatectomy (PROCEDURE), Aquablation Therapy (DEVICE).

Who is sponsoring clinical trial NCT06651632?

This trial is sponsored by PROCEPT BioRobotics, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06651632 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Localized Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Localized Prostate Cancer

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.